Discover
SPRB
Spruce Biosciences, Inc.
44.05
2 x 32.16
2 x 55.32
bid
ask
-
1.49
3.27%
2 @ 04:00 PM
44.05 +0.00 (0.00%)
| Ytd | -49.43% | |
| 1y | -74.87% |
42.80
day range
45.04
41.45
52 week range
176.91
| Open | 44.50 | Prev Close | 45.54 | Low | 42.80 | High | 45.04 | Mkt Cap | 126.60M |
| Vol | 83.76K | Avg Vol | 77.66K | EPS | -39.12 | P/E | N/A | Forward P/E | -0.41 |
| Beta | 3.25 | Short Ratio | 0.10 | Inst. Own | 46.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 51.52 | 200-d Avg | 58.87 | 1yr Est | 1.83 |
SPRB News
businesswire.com
Spruce Biosciences Announces Presentation of MPS IIIB Natural History Data at the 55th Child Neurolo
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage
benzinga.com
Citizens Reiterates Market Outperform on Spruce Biosciences, Maintains $144 Price Target
Citizens analyst Jonathan Wolleben reiterates Spruce Biosciences (NASDAQ:SPRB) with a Market Outp
benzinga.com
Lake Street Initiates Coverage On Spruce Biosciences with Buy Rating, Announces Price Target of $149
Lake Street analyst Daniel Brims initiates coverage on Spruce Biosciences (NASDAQ:SPRB) with a Bu